Blocking the channel: A pharmacologically active antagonist of the two-pore-domain potassium ion channel K2P9.1 (TASK-3)
Tuesday, September 27, 2011 - 10:30
in Biology & Nature
Treatment of neurological conditions such as sleepwake control, cognition, and depression could be possible by modulation of the TWIK-related acid-sensitive K+ ion channel (TASK-3, or K2P9.1).